Editorially Independent Content, Financially Supported by
Thomas A. Ciulla, MD, details a study that examined change of visual acuity versus frequency of anti-VEGF injections over 1 year in patients with neovascular age-related macular degeneration (nAMD). Dr. Ciulla points out key lessons that this study demonstrates.
Anti-VEGF • Neovascular Age-Related Macular Degeneration
13 / 13 Series: 2018 ARVO Annual Meeting